Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority study.

Saved in:
Bibliographic Details
Title: Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority study.
Authors: Shin P; Kaiser Permanente Drug Intelligence and Strategy, Oakland, CA, USA., Niu F; Kaiser Permanente Pharmacy Outcomes Research Group, Bellflower, CA, USA., Nguyen DD; Kaiser Permanente Drug Intelligence and Strategy, Bellflower, CA, USA., Ho SL; Kaiser Permanente Drug Intelligence and Strategy, Oakland, CA, USA., Shah N; Kaiser Permanente Drug Utilization Management, Oakland, CA, USA., Durna L; The Permanente Medical Group, Harbor City, CA, USA., Hui RL; Kaiser Permanente Pharmacy Outcomes Research Group, Oakland, CA, USA.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Mar 27, pp. 10781552261432500. Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-092X
DOI:10.1177/10781552261432500